Momordica charantia L. lowers elevated glycaemia in Type 2 Diabetes Mellitus Patients: Systematic review and Meta-analysis

ConclusionM. charantia adjunct preparations improved glycemic control in T2DM patients. However, this conclusion based on low to very low quality evidences for the primary outcomes and sparse data for several safety outcomes, thus, warrant further research. Particularly needed are the researches that focus on standardizing M. charantia formulation and determine its efficacy and safety in clinical trials with adequate sample size, designed with random sequence generation, allocation concealment of intervention and blinding of both research personnel and participants.Graphical Abstract
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research